Sandoz finalized acquisition of GSK’s cephalosporin antibiotics business

Oct 20, 2021 / by admin / in: Blog


Sandoz – a division of Novartis Group – is a global leader in generic pharmaceuticals and biosimilars, and it is dedicated to discovering new ways to improve and extend people’s lives. The recent news is that Sandoz has acquired GSK’s cephalosporin antibiotics business. The acquisition included the global rights to three brands (Zinnat, Zinacef, and […]

Continue Reading


Let’s do something amazing. Get in Touch!

    Leave a Message